SEARCH
NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Development Talks Medication Compliance
Benzinga
2022-11-07
Views
1
Description
Share / Embed
Download This Video
Report
Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8fanc5" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:35
Super Micro Computer Receives Compliance Warning From Nasdaq As It Files Compliance Plan, Brings On A New Auditor
08:09
NASDAQ: $UNCY Pivotal For The People: An Exciting Clinical Trial & An Interview With UNCY's EVP!
03:47
Focus on our new CSR program with Caroline Le Masne de Chermont, EVP, Legal affairs, Compliance and CSR, Vivendi Group
01:41
Former Universal EVP Doug Neil Named Marketing Brand Chief At NFT
00:57
EVP Search, Play-Calling and More: 5 Important Things From Doug Pederson's Introductory Press Conference
01:41
Former Universal EVP Doug Neil Named Marketing Brand Chief At NFT
00:44
Super Micro Shares Jump 37% After Naming New Auditor Amid Nasdaq Compliance Efforts
00:44
SMCI’s Rollercoaster Year: Rapid Growth, Allegations, And NASDAQ Compliance Struggles
04:19
Getting Doug With High's Doug Benson Talks About His Weirdest Cannabis Moments
03:07
WWE Taps DAZN’s Jamie Horowitz As EVP Development & Digital Expanding | Moon TV News
11:54
Ivanhoe Energy Inc. (NASDAQ: IVAN) Corporate
03:07
WWE Taps DAZN’s Jamie Horowitz As EVP Development & Digital Expanding | OnTrending News